Clinical utility of ctDNA testing in lung cancer

from Illumina Genomics Podcast · host Illumina Genomics Podcast

Atocha Romero, PharmD, PhD, explains the value of liquid biopsy-based comprehensive genomic profiling. Dr. Romero provides an overview of the results of the NADIM II clinical trials and discusses ctDNA testing to monitor disease and guide treatment. Atocha Romero, PharmD, PhD, is the director of the Liquid Biopsy Laboratory of the Medical Oncology Department at the Hospital Universitario Puerta de Hierro in Madrid, Spain.

Episode metadata supplied by the publisher feed · Published Apr 10, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Clinical utility of ctDNA testing in lung cancer

0:00 4:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Illumina Genomics Podcast?

This episode is 4 minutes long.

When was this Illumina Genomics Podcast episode published?

This episode was published on April 10, 2024.

Can I download this Illumina Genomics Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!